TW201023891A - Anti-ferroportin 1 monoclonal antibodies and uses thereof - Google Patents

Anti-ferroportin 1 monoclonal antibodies and uses thereof Download PDF

Info

Publication number
TW201023891A
TW201023891A TW098140185A TW98140185A TW201023891A TW 201023891 A TW201023891 A TW 201023891A TW 098140185 A TW098140185 A TW 098140185A TW 98140185 A TW98140185 A TW 98140185A TW 201023891 A TW201023891 A TW 201023891A
Authority
TW
Taiwan
Prior art keywords
ser
thr
val
gly
leu
Prior art date
Application number
TW098140185A
Other languages
English (en)
Chinese (zh)
Inventor
Donmienne Doen Mun Leung
Peng Luan
Joseph Vincent Manetta
Ying Tang
Derrick Ryan Witcher
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of TW201023891A publication Critical patent/TW201023891A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/30Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77Internalization into the cell
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW098140185A 2008-12-05 2009-11-25 Anti-ferroportin 1 monoclonal antibodies and uses thereof TW201023891A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12007608P 2008-12-05 2008-12-05
US23981809P 2009-09-04 2009-09-04

Publications (1)

Publication Number Publication Date
TW201023891A true TW201023891A (en) 2010-07-01

Family

ID=41683589

Family Applications (1)

Application Number Title Priority Date Filing Date
TW098140185A TW201023891A (en) 2008-12-05 2009-11-25 Anti-ferroportin 1 monoclonal antibodies and uses thereof

Country Status (25)

Country Link
EP (1) EP2373335B1 (enExample)
JP (1) JP5713917B2 (enExample)
KR (1) KR101353117B1 (enExample)
CN (1) CN102238962B (enExample)
AR (1) AR074398A1 (enExample)
AU (1) AU2009322587B2 (enExample)
BR (1) BRPI0922288A2 (enExample)
CA (1) CA2745618C (enExample)
CY (1) CY1117355T1 (enExample)
DK (1) DK2373335T3 (enExample)
EA (1) EA020472B1 (enExample)
ES (1) ES2566343T3 (enExample)
HR (1) HRP20160302T1 (enExample)
HU (1) HUE028585T2 (enExample)
IL (1) IL212731A0 (enExample)
MX (1) MX2011005939A (enExample)
NZ (1) NZ592545A (enExample)
PA (1) PA8849601A1 (enExample)
PL (1) PL2373335T3 (enExample)
SG (1) SG171960A1 (enExample)
SI (1) SI2373335T1 (enExample)
TW (1) TW201023891A (enExample)
UA (1) UA104741C2 (enExample)
WO (1) WO2010065496A1 (enExample)
ZA (1) ZA201103941B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104284677A (zh) * 2012-05-14 2015-01-14 霍夫曼-拉罗奇有限公司 用于肿瘤诊断和治疗的组合物和方法
EP3788065B1 (en) 2018-04-30 2025-08-27 The Children's Hospital Of Philadelphia Improving anemias by combining agents
KR20220088699A (ko) 2019-09-27 2022-06-28 디스크 메디슨, 인크. 골수섬유증 및 관련 상태의 치료 방법
CN110806486B (zh) * 2019-11-23 2023-03-21 中南大学湘雅三医院 Mafg/as1/pcbp2/fpn1调控轴作为靶位点检测试剂的应用
KR20230012539A (ko) 2020-05-13 2023-01-26 디스크 메디슨, 인크. 골수섬유증을 치료하기 위한 항-헤모주벨린 (hjv) 항체
CN113980987A (zh) * 2021-12-06 2022-01-28 上海市农业科学院 一种提高植物抗镍性能的PgIREG1S和AlATP-PRTS双基因组及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7166448B1 (en) * 1999-05-10 2007-01-23 Children's Medical Center Corproation Ferroportin1 nucleic acids and proteins
IT1319221B1 (it) * 2000-10-17 2003-09-26 Antonello Pietrangelo Mutazioni nel gene della ferroportina 1 associata ad emocromatosiereditaria.
CA2711826C (en) * 2008-01-25 2018-02-27 Amgen Inc. Ferroportin antibodies and methods of use

Also Published As

Publication number Publication date
MX2011005939A (es) 2011-06-27
EP2373335B1 (en) 2016-02-24
JP2012510814A (ja) 2012-05-17
AR074398A1 (es) 2011-01-12
ES2566343T3 (es) 2016-04-12
CN102238962A (zh) 2011-11-09
JP5713917B2 (ja) 2015-05-07
ZA201103941B (en) 2012-11-28
NZ592545A (en) 2012-12-21
AU2009322587B2 (en) 2013-09-26
DK2373335T3 (en) 2016-05-02
HRP20160302T1 (hr) 2016-04-22
PA8849601A1 (es) 2010-07-27
CN102238962B (zh) 2014-02-12
HK1158977A1 (zh) 2012-07-27
UA104741C2 (uk) 2014-03-11
CA2745618A1 (en) 2010-06-10
BRPI0922288A2 (pt) 2018-08-28
EA020472B1 (ru) 2014-11-28
EP2373335A1 (en) 2011-10-12
CY1117355T1 (el) 2017-04-26
AU2009322587A1 (en) 2011-07-28
SI2373335T1 (sl) 2016-04-29
IL212731A0 (en) 2011-07-31
SG171960A1 (en) 2011-07-28
KR20110084996A (ko) 2011-07-26
WO2010065496A1 (en) 2010-06-10
PL2373335T3 (pl) 2016-08-31
EA201170764A1 (ru) 2011-12-30
CA2745618C (en) 2014-06-10
HUE028585T2 (en) 2016-12-28
KR101353117B1 (ko) 2014-02-17

Similar Documents

Publication Publication Date Title
CN113423733B (zh) 结合tslp的抗体及其用途
KR102473028B1 (ko) 항-tim-3 항체 및 조성물
CN101501072B (zh) 与人il-17结合的抗体分子
RU2730674C2 (ru) Антитела, связывающиеся с человеческим каннабиноидным рецептором 1 (св1)
US8679497B2 (en) Anti-ferroportin 1 monoclonal antibodies and uses thereof
AU2016322814A1 (en) Polyomavirus neutralizing antibodies
CN113150144A (zh) 肿瘤坏死因子样配体1a特异性抗体及其组合物和用途
KR20150139909A (ko) Fap 및 dr5에 특이적인 이중특이성 항체, dr5에 특이적인 항체 및 사용 방법
TW201008579A (en) Anti-Fn14 antibodies and uses thereof
AU2018309090B2 (en) Method of conjugation of cys-mAbs
AU2019339334B2 (en) CD200R agonist antibodies and uses thereof
AU2020322569A1 (en) Humanized anti-IL17A antibody and use thereof
DK2373335T3 (en) Monoclonal anti-ferroportin 1 antibodies and uses thereof
CA3225077A1 (en) Methods of treating neurological diseases
CN108601833B (zh) 甲状旁腺激素-抗rankl抗体融合化合物
US20240076386A1 (en) Anti-e-selectin antibodies, compositions and methods of use
CN118804927A (zh) 抗b7-h7抗体或其抗原结合片段及制备方法和应用
KR20210018192A (ko) 항인간 tlr7 항체
TW202246350A (zh) 血漿激肽釋放素抗體及其用途
RU2834713C1 (ru) Антитела, связывающие il4r, и их применение
KR102902330B1 (ko) 항인간 tlr7 항체
HK40075480A (en) Anti-e-selectin antibodies, compositions and methods of use
HK1256948B (en) Parathyroid hormone - anti-rankl antibody fusion compounds
HK1179279A (en) Antibodies with ph dependent antigen binding